| Jonathan James Oppong Amoakohene, PA-C | |
|
7710 Garth Rd Ste A, Baytown, TX 77521-8809 | |
| (281) 783-8162 | |
| Not Available |
| Full Name | Jonathan James Oppong Amoakohene |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 7710 Garth Rd Ste A, Baytown, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356832992 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | PENDING (Texas) | Secondary |
| 363A00000X | Physician Assistant | PA12090 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nluc Pllc | 3072752302 | 227 |
| Next Level Mv Llc | 5991062085 | 136 |
News Archive
As COVID-19 threatens to derail more than a decade's worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions of malaria resources and interruptions to prevention programmes may cost thousands of lives.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
Peregrine Pharmaceuticals, Inc. has announced that it has licensed worldwide exclusive rights to a novel anti-angiogenesis technology from The University of Texas M. D. Anderson Cancer Center.
Significant public attention has recently been focused on the development of new anti-influenza (flu) vaccines that provide protection against a broad spectrum of viral strains.
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage process.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan James Oppong Amoakohene, PA-C 2925 Briarpark Dr Ste 575, Houston, TX 77042-3776 Ph: (832) 626-2842 | Jonathan James Oppong Amoakohene, PA-C 7710 Garth Rd Ste A, Baytown, TX 77521-8809 Ph: (281) 783-8162 |
News Archive
As COVID-19 threatens to derail more than a decade's worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions of malaria resources and interruptions to prevention programmes may cost thousands of lives.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
Peregrine Pharmaceuticals, Inc. has announced that it has licensed worldwide exclusive rights to a novel anti-angiogenesis technology from The University of Texas M. D. Anderson Cancer Center.
Significant public attention has recently been focused on the development of new anti-influenza (flu) vaccines that provide protection against a broad spectrum of viral strains.
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage process.
› Verified 7 days ago